Drug Deal Disclosure Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4355 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4355 To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES April 21, 2026 Mr. Wyden (for himself, Mr. Welch, Ms. Warren, Mr. Gallego, Mr. Merkley, Mr. Lujan, Ms. Baldwin, Mr. Whitehouse, Mr. Kelly, Mr. Sanders, Mr. Warner, Ms. Smith, Ms. Hassan, Ms. Cortez Masto, Mr. Bennet, Mr. Warnock, Ms. Hirono, and Ms. Cantwell) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Drug Deal Disclosure Act''. SEC. 2. RELEASE OF INFORMATION RELATING TO MOST-FAVORED-NATION PRICING AGREEMENTS. (a) Public Release of Information.-- (1) In general.--Not later than 30 days after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this Act as the ``Secretary''), subject to subsections (b) and (c), shall make publicly available in a centralized, searchable, and downloadable format all records, documents, communications, meeting notes, memoranda, directives, logs, metadata, contracts, and agreements as pr